Drug Profile
Research programme: implantable therapeutics - Valera Pharmaceuticals
Alternative Names: Tamsulosin - Valera; VP 005; VP 006Latest Information Update: 01 Feb 2007
Price :
$50
*
At a glance
- Originator Valera Pharmaceuticals
- Class
- Mechanism of Action Alpha-1a adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia; Enuresis; Interstitial cystitis
Most Recent Events
- 01 Feb 2007 Discontinued - Preclinical for Benign prostatic hyperplasia in USA (SC)
- 01 Feb 2007 Discontinued - Preclinical for Enuresis in USA (SC)
- 01 Feb 2007 Discontinued - Preclinical for Interstitial cystitis in USA (SC)